Given the glucose‐dependent nature of GLP‐1 induced insulin secretion and retention of bioactivity in type 2 diabetes (Nauck, Kleine, et al., 1993), drugs based on the biological action of this hormone were rapidly translated to benefits in humans (Baggio & Drucker, 2007). The gene discussed is INS; the disease is type 2 diabetes mellitus.